HomeAbout usHospitalsSearchLogin
Your medical data, safe and secure.
Name
Afatinib
Description
Afatinib is a tyrosine kinase inhibitor which is a 4-anilinoquinazoline. It is prepared has the dimaleate salt. FDA approved on July 12, 2013.
No brand information found.
